• Company
    • Craneware At-a-Glance
    • Craneware Partners and Sponsorships
    • Craneware Health (UK)
    • Craneware’s Executive Leadership
    • History
    • Offices
    • Contact Us
  • Careers
  • Investors
    • Corporate governance
    • Share Information
    • Directors
    • Financial Reports and Presentations
    • History
    • Announcements
    • AIM Rule 26
    • Advisors & Contacts
  • Login
    • Online Reference Toolkit®
    • Reference Plus™
    • InSight products
CranewareCranewareCranewareCraneware
  • Home
  • What We Do
    • Patient Engagement
      • InSight Medical Necessity®
      • InSight Medical Necessity® MEDITECH
      • Trisus® Patient Payment
      • Patient Charge Estimator®
    • Charge Capture & Pricing
      • Chargemaster Toolkit®
      • Chargemaster Toolkit® Discovery Viewer
      • Chargemaster Toolkit® Corporate Discovery Viewer
      • Chargemaster Toolkit® – CAH
      • Reference Plus™
      • Online Reference Toolkit®
      • Physician Revenue Toolkit®
      • Pricing Analyzer™
      • Pharmacy ChargeLink®
      • Supplies ChargeLink®
      • Supplies Assistant
      • Interface Scripting Module
    • Claims Analysis
      • Trisus® Claims Informatics
    • Revenue Recovery & Retention
      • InSight Audit®
      • InSight Denials®
    • Cost Analytics
    • Professional Services
      • Revenue Integrity Package
      • Chargemaster Review
      • Pricing Analysis Review
      • Appeal Services
  • Learning
    • Blog
    • Case Studies
    • White Papers
    • RAC Audit Resources
    • Craneware Insights Articles
    • Webinar Library
    • Craneware Performance Center
    • Join Support Session
  • News & Events
    • Financial Performance Summit
    • Webinars & Upcoming Events
    • Press Releases
    • Articles & Publications

Holding(s) in Company – 11 January 2012

    Home Holding(s) in Company – 11 January 2012
    TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

    1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: CRANEWARE PLC

    2 Reason for the notification (please tick the appropriate box or boxes):
    An acquisition or disposal of voting rights YES
    An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached NO
    An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments NO
    An event changing the breakdown of voting rights NO
    Other (please specify): NO

    3. Full name of person(s) subject to the notification obligation: Standard Life Investments Ltd
    4. Full name of shareholder(s) (if different from 3.): Vidacos Nominees
    5. Date of the transaction and date on which the threshold is crossed or reached: 10 January 2012
    6. Date on which issuer notified: 11 January 2012
    7. Threshold(s) that is/are crossed or reached: 11%

    8. Notified details:
    A: Voting rights attached to shares
    Class/type of shares
    if possible using the ISIN CODE
    Situation previous to the triggering transaction Resulting situation after the triggering transaction
    Number of Shares Number of Voting Rights Number of shares Number of voting rights % of voting rights
      Direct Indirect Direct Indirect
    GB00B2425G68 3,155,516 3,155,516 2,726,636 397,469 2,329,167 1.473% 8.631%

    B: Qualifying Financial Instruments
    Resulting situation after the triggering transaction
    Type of financial instrument Expiration date Exercise/Conversion Period Number of voting rights that may be acquired if the instrument is exercised/ converted. % of voting rights
             

    C: Financial Instruments with similar economic effect to Qualifying Financial Instruments
    Resulting situation after the triggering transaction
    Type of financial instrument Exercise price Expiration date Exercise/Conversion period Number of voting rights instrument refers to % of voting rights
              Nominal Delta
       

    Total (A+B+C)
    Number of voting rights Percentage of voting right
    2,726,636 10.104%

    9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:
     

    Proxy Voting:
    10. Name of the proxy holder:  
    11. Number of voting rights proxy holder will cease to hold:  
    12. Date on which proxy holder will cease to hold voting rights:  

    13. Additional information:  
    14. Contact name: Craig Preston
    15. Contact telephone number: 01506 407 666

    TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

    1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: CRANEWARE PLC

    2 Reason for the notification (please tick the appropriate box or boxes):
    An acquisition or disposal of voting rights YES
    An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached NO
    An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments NO
    An event changing the breakdown of voting rights NO
    Other (please specify): NO

    3. Full name of person(s) subject to the notification obligation: Kames Capital
    4. Full name of shareholder(s) (if different from 3.):  
    5. Date of the transaction and date on which the threshold is crossed or reached: 10th January 2012
    6. Date on which issuer notified: 11th January 2012
    7. Threshold(s) that is/are crossed or reached: 9%

    8. Notified details:
    A: Voting rights attached to shares
    Class/type of shares
    if possible using the ISIN CODE
    Situation previous to the triggering transaction Resulting situation after the triggering transaction
    Number of Shares Number of Voting Rights Number of shares Number of voting rights % of voting rights
      Direct Indirect Direct Indirect
    GB00B2425G68 2,506,608 2,506,608 1,651,132 1,651,132 569,529 6.11% 2.11%

    B: Qualifying Financial Instruments
    Resulting situation after the triggering transaction
    Type of financial instrument Expiration date Exercise/Conversion Period Number of voting rights that may be acquired if the instrument is exercised/ converted. % of voting rights
             

    C: Financial Instruments with similar economic effect to Qualifying Financial Instruments
    Resulting situation after the triggering transaction
    Type of financial instrument Exercise price Expiration date Exercise/Conversion period Number of voting rights instrument refers to % of voting rights
    Contract for Difference n/a n/a n/a 23,311 Nominal Delta
    0.09% 1

    Total (A+B+C)
    Number of voting rights Percentage of voting right
    2,243,972 8.31%

    9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:
    Kames Capital:-
    Kames Capital plc
    Kames Capital Management Ltd
    Kames Capital ICVC
    Kames Capital VCIC

    Proxy Voting:
    10. Name of the proxy holder: Kames Capital
    11. Number of voting rights proxy holder will cease to hold:  
    12. Date on which proxy holder will cease to hold voting rights:  

    13. Additional information:  
    14. Contact name: Craig Preston
    15. Contact telephone number: 01506 407 666

    Let’s Talk

    Request a demo

    Follow Us

    Accolades

    #1 in KLAS since 2006

    KLAS LogoChargemaster Toolkit® is ranked No.1 in the Chargemaster Management category for the twelfth year in a row (2006 – 2018.) in the "2018 Best in KLAS Awards: Software & Services" report, published January 2018. Data © 2017 KLAS Enterprises, LLC. All rights reserved. www.KLASresearch.com www.KLASresearch.com

    Peer Reviewed by HFMA®

    HFMA Peer Review Logo*HFMA staff and volunteers determined that Craneware's Chargemaster Toolkit® has met specific criteria developed under the HFMA Peer Review Process. HFMA does not endorse or guarantee the use of these products.

    3340 Peachtree Rd. NE, Suite 850, Atlanta, GA 30326

      support@craneware.com

    +877 624 2792

    About Craneware

    Craneware (AIM: CRW.L) is the market leader in software and supporting services that help healthcare providers improve margins so they can invest in quality patient outcomes. The company’s flagship solution, Chargemaster Toolkit®, has earned the KLAS No.1 ranking in Revenue Cycle – Chargemaster Management since 2006 and is part of our value cycle management suite, which includes Patient Engagement, Charge Capture & Pricing, Coding Integrity, Revenue Recovery & Retention, and Cost Analytics solutions.

    Copyright 2017 | Craneware, Inc. | All Rights Reserved
    • 3 of the Most Common Charge Capture Errors
      • Thank you for downloading
    • 5 Keys to Getting Started with Charge Capture Audits
      • Thank you for downloading
    • 7 Statistics You Need To Know About Charge Capture
      • Thank you for downloading
    • Accolades
    • AHRMM17
    • Better Outcomes For All
    • CDM Technology
      • How Current is your CDM data?
        • Download Infographic
        • Learn More
      • Learn More
    • Cerner Health Conference 2017
    • Changes in Pharmacy Cost and Reimbursement
    • Contact Craneware
    • Craneware’s blog
    • Craneware, Inc. Privacy Policy
    • Customer Services Holiday Schedule
    • Download Pricing Analysis
    • Home
    • PCL Touch
    • Pharmacy Revenue Integrity
      • Schedule a conversation with our experts
    • Pricing Analyzer™ Calculator
    • Pricing Strategy and Hospital Margins
      • Schedule a conversation with our experts
    • Request a Craneware Product Demonstration
    • Request Pricing Analysis
    • Retrospective Charge Capture Audits
    • Revenue Integrity Best Practice Sharing Session
    • Thank you for scanning our QR Code
      • Your entry has been received
    • Thank you for scanning our QR Code
      • Your entry has been received
    • Thank you for scanning our QR Code
      • Your entry has been received
    • The Value Cycle
    • What does Patient Engagement Mean to You?
    • Where Errors Can Occur In The Charge Capture Process
      • Thank you for downloading
    • Yop Poll Archive
    • Your message has been received
    • Your message has been received
    • Your message has been received
    • First Day of Dealings
    • 2018 NYC User Group
      • 2018 New York User Group Registration
    • 2018 Ohio User Group
    • ASHP Midyear
      • Thank you for your interest in ASHP Midyear
    • Financial Performance Summit
      • 2018 Craneware Financial Performance Summit Registration
        • Thank you for registering
      • Financial Performance Summit – Photos
    • HFMA ANI 2017
      • Booth Appointment
      • Thank you for visiting us at HFMA ANI 2017
    • miCheckin
    • Trading on PLUS Markets
    • What We Do
      • Chargemaster Toolkit® Corporate Discovery Viewer
      • Patient Charge Estimator®
      • Supplies Assistant
      • Trisus® Patient Payment
      • InSight Audit®
      • InSight Medical Necessity®
      • InSight Medical Necessity® MEDITECH
      • Trisus® Claims Informatics
      • InSight Denials®
      • Interface Scripting Module
      • Patient Engagement Solutions
      • Chargemaster Toolkit® Discovery Viewer
      • Revenue Recovery & Retention
      • Charge Capture & Pricing
      • Pricing Analyzer™
      • Physician Revenue Toolkit®
      • Online Reference Toolkit®
      • Reference Plus™
      • Chargemaster Toolkit® – CAH
      • Chargemaster Toolkit®
      • Craneware Healthcare Intelligence
        • Contact Craneware Healthcare Intelligence
        • About Craneware Healthcare Intelligence
        • CHI Leadership
      • Trisus®
      • Pharmacy ChargeLink®
      • Supplies ChargeLink®
    • Learning
      • All Insights Articles
        • January 2015 Integrated Outpatient Code Editor (I/OCE) Specifications Version 16.0
      • Chargemaster Review: Step-by-Step Process for a Clean CDM
      • Craneware Case Studies
      • Getting Clinical Departments Engaged in the CDM Review Process
      • Physician Specialty Pricing Report
        • Your form submission has been received
      • Your message has been received
      • RAC Audit Resources
      • Craneware White Papers
        • Revenue Integrity in Healthcare
        • Supply Chain and Revenue Cycle Integration
        • Three Ways to Overcome Chargemaster Review Roadblocks
        • Chargemaster Automation: A Strategic Asset for Achieving Revenue Integrity
        • RAC Best Practices: Utilization Management
        • Building a Better Chargemaster With Supply Data Integration
        • RAC Best Practices: Medical Record Preparation and Submission
      • Webinar Library
      • JW Modifier FAQ and Drug List Download
    • Professional Services
      • Appeal Services
      • Pricing Analysis Review
      • Chargemaster Review
      • Revenue Integrity Package
    • Annual Report & Accounts
    • Company
      • Craneware At-a-Glance
      • Offices
        • Needham Office
        • Pittsburgh Office
        • Scottsdale Office
        • Edinburgh Office
        • Atlanta Office
      • Craneware Partners and Sponsorships
      • Executive Leadership
      • Careers
    • Investors Documents
    • Investors
      • AIM Rule 26
        • AIM Securities Information
        • Documents
        • Strategy
        • Advisors
        • Announcements
        • Financial Reports and Presentations
      • Directors
        • Russ Rudish
        • Colleen M. Blye
        • Ron F. Verni
        • Craig T. Preston
        • Keith Neilson
        • George R. Elliott
      • History
      • Corporate governance
    • News & Events
      • Press Releases
        • Press Releases – 2015
      • Webinars & Upcoming Events
      • Articles & Publications
        • Articles & Publications – 2014
        • Articles & Publications – 2015
        • Articles & Publications – 2016
        • Articles & Publications – 2017
        • Articles & Publications – 2013
        • Articles & Publications – 2012
    • Block Listing
    • Dividend Declaration
    • Trading Update – 11 January 2008
    • Director Shareholding – 9 September 2010
    • October 2009 Blocklisting Interim Review
    • Dividend Currency Election – 6 November 2009
    • Grant of Options – 23 December 2009
    • Dividend Currency Election – 5 March 2010
    • 15th April 2010 Blocklisting
    • Additional Listing – 15 March 2011
    • Notice of Interim Results
    • Reseller Agreement with Premier
    • Total Voting Rights – 28 April 2011
    • Director Declaration
    • Director Shareholding Amendment
    • Interim Results
    • Total Voting Rights – 01 June 2011
    • Investor and Analyst Presentation
    • Launch of ADR Programme
    • Craneware InSight Contract Win
    • Trading Update – 30 June 2010
    • Holding(s) in Company – 07 June 2011
    • Notice of Final Results
    • Price Monitoring Extension – 19 August 2011
    • Second Price Monitoring Extn – 19 August 2011
    • Price Monitoring Extension – 22 August 2011
    • Second Price Monitoring Extn – 22 August 2011
    • Holding(s) in Company – 22 August 2011
    • Director Shareholding – 31 August 2011
    • Result of AGM 2010
    • Dividend Currency Election – 12 November 2010
    • Grant of Options – 26 September 2011
    • Adviser – Change of Name
    • Total Voting Rights – 21 October 2011
    • Holding(s) in Company – 28 January 2011
    • Posting of Annual Report & Notice of AGM
    • Trading Update – 10 July 2008
    • Acquisition of ClaimTrust
    • Director Shareholding – 25 October 2011
    • Holding(s) in Company – 10 March 2011
    • Total Voting Rights – 01 November 2011
    • Additional Listing – 14 March 2011
    • AGM Statement – 10 November 2011
    • Result of AGM
    • Appointment of a Director
    • Blocklisting Interim Review – 01 November 2011
    • Total Voting Rights – 31 March 2011
    • Trading Update – 10 January 2012
    • Holding(s) in Company – 11 January 2012
    • Holding(s) in Company – 6 April 2011
    • Blocklisting Application
    • Holding(s) in Company – 16 January 2012
    • 2008 Annual Report and Notice of AGM
    • Holding(s) in Company – 31 January 2012
    • Price Monitoring Extension – 20 April 2011
    • Holding(s) in Company – 27 April 2011
    • Blocklisting Interim Review – 27 April 2011
    • Holding(s) in Company – 20 February 2012
    • Half Yearly Report
    • Channel Partner Contract Win
    • Total Voting Rights – 27 April 2012
    • AGM Statement 2012
    • Result of AGM 2012
    • Dividend Currency Election – 9 November 2012
    • Notice of Results – 23 February 2009
    • 2009 Annual Report and Notice of AGM
    • Help
    • Notice of Results – 01 February 2012
    • Terms & Conditions
    • Total Voting Rights
    • Total Voting Rights – 13 August 2012
    • Dividend Currency Election – 18 March 2013
    • Result of AGM
    • Total Voting Right – 15 April 2013
    • Application Submission Confirmation
    • Schedule a conversation
    Craneware
    • Home
    • What We Do
      ▼
      • Patient Engagement
        ▼
        • InSight Medical Necessity®
        • InSight Medical Necessity® MEDITECH
        • Trisus® Patient Payment
        • Patient Charge Estimator®
      • Charge Capture & Pricing
        ▼
        • Chargemaster Toolkit®
        • Chargemaster Toolkit® Discovery Viewer
        • Chargemaster Toolkit® Corporate Discovery Viewer
        • Chargemaster Toolkit® – CAH
        • Reference Plus™
        • Online Reference Toolkit®
        • Physician Revenue Toolkit®
        • Pricing Analyzer™
        • Pharmacy ChargeLink®
        • Supplies ChargeLink®
        • Supplies Assistant
        • Interface Scripting Module
      • Claims Analysis
        ▼
        • Trisus® Claims Informatics
      • Revenue Recovery & Retention
        ▼
        • InSight Audit®
        • InSight Denials®
      • Cost Analytics
      • Professional Services
        ▼
        • Revenue Integrity Package
        • Chargemaster Review
        • Pricing Analysis Review
        • Appeal Services
    • Learning
      ▼
      • Blog
      • Case Studies
      • White Papers
      • RAC Audit Resources
      • Webinar Library
      • Craneware Performance Center
      • Join Support Session
    • News & Events
      ▼
      • Financial Performance Summit
      • Webinars & Upcoming Events
      • Press Releases
      • Articles & Publications
    • Company
      ▼
      • Craneware At-a-Glance
      • Craneware Partners and Sponsorships
      • Craneware Health (UK)
      • Craneware’s Executive Leadership
      • History
      • Offices
      • Contact Craneware
    • Careers
    • Investors
      ▼
      • Corporate governance
      • Share Information
      • Directors
      • Financial Reports and Presentations
      • History
      • Announcements
      • AIM Rule 26
      • Advisors & Contacts
    • Login
      ▼
      • Online Reference Toolkit®
      • Reference Plus™
      • InSight products